Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, September 25, 2023
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
[ Mon, Sep 25th 2023
] - WOPRAI
Fri, September 22, 2023
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
[ Fri, Sep 22nd 2023
] - WOPRAI
Ed Arce Reiterated (AUPH) at Strong Buy and Held Target at $15 on, Sep 22nd, 2023
Ed Arce of HC Wainwright & Co., Reiterated "Aurinia Pharmaceuticals Inc." (AUPH) at Strong Buy and Held Target at $15 on, Sep 22nd, 2023.
Ed has made no other calls on AUPH in the last 4 months.
There is 1 other peer that has a rating on AUPH. Out of the 1 peers that are also analyzing AUPH, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $15 on, Thursday, July 6th, 2023
